ALLIANCEBERNSTEIN L.P. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 97 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$3,033,000
-56.3%
150,459
-19.0%
0.00%
-66.7%
Q2 2021$6,936,000
+52.3%
185,857
+4.3%
0.00%
+50.0%
Q1 2021$4,555,000
+44.8%
178,157
+24.8%
0.00%
+100.0%
Q4 2020$3,145,000
+22.5%
142,7590.0%0.00%0.0%
Q3 2020$2,568,000
-40.8%
142,759
-16.3%
0.00%
-66.7%
Q2 2020$4,335,000
+68.3%
170,650
+21.8%
0.00%
+50.0%
Q1 2020$2,575,000
-18.1%
140,150
-1.8%
0.00%0.0%
Q4 2019$3,143,000
+233.7%
142,650
+117.5%
0.00%
+100.0%
Q3 2019$942,000
-8.8%
65,6000.0%0.00%0.0%
Q2 2019$1,033,000
+21.8%
65,600
+13.3%
0.00%0.0%
Q1 2019$848,000
+105.8%
57,900
+50.4%
0.00%
Q4 2018$412,000
-9.6%
38,500
+28.8%
0.00%
Q3 2018$456,000
+196.1%
29,900
+137.3%
0.00%
Q2 2018$154,000
+55.6%
12,600
+207.3%
0.00%
Q1 2015$99,000
+371.4%
4,100
+215.4%
0.00%
Q4 2014$21,000
-36.4%
1,300
-50.0%
0.00%
Q3 2014$33,000
-44.1%
2,6000.0%0.00%
Q2 2014$59,0002,6000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 2,456,595$49,525,0009.00%
COMMODORE CAPITAL LP 1,292,251$26,052,0006.87%
Bain Capital Life Sciences Investors, LLC 3,080,237$62,098,0003.85%
GREAT POINT PARTNERS LLC 799,999$16,128,0003.76%
DAFNA Capital Management LLC 587,456$11,843,0003.14%
Eagle Health Investments LP 406,525$8,196,0002.60%
RTW INVESTMENTS, LP 7,582,396$152,861,0002.30%
Parkman Healthcare Partners LLC 209,686$4,227,0001.07%
Palo Alto Investors LP 855,713$17,251,0001.04%
Lombard Odier Asset Management (Switzerland) SA 701,305$14,138,0000.88%
View complete list of DICERNA PHARMACEUTICALS INC shareholders